Department of Medicine
-
June 3, 2022
Food allergy linked to lower risk of SARS-CoV-2 infection
-
June 2, 2022
Study explores positioning options to improve COVID mortality
Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients. -
June 2, 2022
Scale measures confidence with telehealth technology
Vanderbilt's Digital Health Care Literacy Scale uses responses to three brief items to assess whether patients or caregivers are apt to have the confidence and basic know-how required to use digital health care services such as telehealth. -
June 2, 2022
VUMC renewed as a Comprehensive Hypertension Center
The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification, -
May 26, 2022
Conquer Cancer awards given to five hematology-oncology fellows
Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7. -
May 25, 2022
Study seeks to improve gender equity for liver transplantation waiting list
Women who need a liver transplant are more likely to spend more time on a waiting list, become too sick for transplant or die compared to men. To improve equity, a recently published Vanderbilt-led study suggests a sex adjustment to criteria for MELD (model for end-stage liver disease), which determines allocation of transplanted livers. -
May 24, 2022
Diabetes, cardiovascular drug targets
Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.